OverviewSuggest Edit

Pfizer is a research-based biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products. It operates through three business segments: Pfizer Biopharmaceuticals Group, Upjohn, and Consumer Healthcare. The Company's healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, nutritional products, and consumer health care products. 

TypePublic
Founded1849
HQNew York, US
Websitepfizer.com
Employee Ratings4
Culture scoreB

Latest Updates

Employees (est.) (Dec 2019)88,300(-4%)
Job Openings1,400
Revenue (FY, 2019)$51.8 B(-3%)
Share Price (May 2020)$37.5

Key People/Management at Pfizer

Frank D'Amelio

Frank D'Amelio

Chief Financial Officer and Executive Vice President, Global Supply and Business Operations
Mikael Dolsten

Mikael Dolsten

Chief Scientific Officer and President, Worldwide Research, Development and Medical
Angela Hwang

Angela Hwang

Group President, Pfizer Biopharmaceuticals Group
Rady Johnson

Rady Johnson

Executive Vice President, Chief Compliance, Quality & Risk Officer
Doug Lankler

Doug Lankler

Executive Vice President, General Counsel
Dawn Rogers

Dawn Rogers

Executive Vice President, Chief Human Resources Officer
Show more

Pfizer Office Locations

Pfizer has offices in New York, Melrose Park, Wien, Minsk and in 35 other locations
New York, US (HQ)
235 E 42nd St
Melrose Park, AU
38-42 Wharf Rd
Wien, AT
1 Floridsdorfer Hauptstraße
Minsk, BY
403 8 praspiekt Dziaržynskaha
Ixelles, BE
17 Boulevard de la Plaine
Sofia, BG
115 Boulevard "Tsarigradsko shose"
Show all (39)

Pfizer Financials and Metrics

Pfizer Revenue

Embed Graph
View revenue for all periods
Pfizer's revenue was reported to be $51.75 b in FY, 2019
USD

Revenue (Q1, 2020)

12.0b

Gross profit (Q1, 2020)

9.7b

Gross profit margin (Q1, 2020), %

80.2%

Net income (Q1, 2020)

3.4b

EBIT (Q1, 2020)

3.4b

Market capitalization (22-May-2020)

208.3b

Closing stock price (22-May-2020)

37.5

Cash (29-Mar-2020)

2.2b

EV

258.4b
Pfizer's current market capitalization is $208.3 b.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

48.9b52.8b52.5b53.6b51.8b

Revenue growth, %

(2%)8%(1%)

Cost of goods sold

9.6b12.3b11.2b11.2b10.2b

Gross profit

39.2b40.5b41.3b42.4b41.5b
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

13.0b13.1b13.0b12.8b12.9b13.2b12.9b13.5b13.3b13.1b13.3b12.7b12.0b

Cost of goods sold

2.9b3.2b3.1b2.5b2.7b2.8b2.6b2.9b2.7b2.4b2.6b2.6b2.4b

Gross profit

10.2b10.0b10.0b10.3b10.2b10.3b10.3b10.6b10.6b10.7b10.7b10.1b9.7b

Gross profit Margin, %

78%76%76%81%79%78%80%78%80%81%81%79%80%
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

3.6b2.6b1.3b1.1b1.3b

Accounts Receivable

8.0b8.7b

Prepaid Expenses

2.5b2.6b

Inventories

7.5b6.8b7.6b7.5b8.3b
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

2.6b3.4b2.1b4.1b2.6b2.8b2.3b2.7b3.6b1.9b1.8b2.8b2.2b

Accounts Receivable

9.6b9.8b9.4b9.9b

Prepaid Expenses

2.6b2.5b3.0b

Inventories

7.6b7.6b7.5b7.4b7.6b7.9b8.1b8.1b8.2b8.0b8.2b8.2b8.4b
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

7.0b7.2b21.4b11.2b16.3b

Depreciation and Amortization

5.2b5.8b6.3b6.4b6.0b

Inventories

(199.0m)365.0m(357.0m)(717.0m)(1.0b)

Accounts Payable

254.0m871.0m46.0m431.0m(564.0m)
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

3.0b5.1b6.5b3.1b6.2b9.1b3.6b7.4b11.6b3.9b8.9b16.6b3.4b

Depreciation and Amortization

1.4b2.8b4.2b1.6b3.1b4.7b1.6b3.1b4.7b

Cash From Operating Activities

1.8b5.4b1.0b1.6b4.8b9.7b2.0b5.8b11.1b1.7b4.3b8.8b3.1b

Purchases of PP&E

(301.0m)(702.0m)(1.1b)(358.0m)(806.0m)(1.3b)(386.0m)(810.0m)(1.4b)(460.0m)(939.0m)(1.5b)(463.0m)
USDY, 2020

EV/EBIT

76 x

EV/CFO

82.5 x

Financial Leverage

2.5 x
Show all financial metrics

Pfizer Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017

Active Clinical Studies

448 338

Phase III Trials Products

22 30 34 29

Discovery Projects

91 90 96 87

Total Units Delivered

74 b
Show all operating metrics

Pfizer Acquisitions / Subsidiaries

Company NameDateDeal Size
Array BioPharmaJune 18, 2019$11.40 b
TherachonMay 08, 2019$340 m
MedivationAugust 22, 2016$14 b
Bamboo TherapeuticsAugust 01, 2016$654 m
BIND Therapeutics, Inc.July 27, 2016$40 m
Anacor PharmaceuticalsJune 24, 2016$5.20 b
HospiraFebruary 05, 2015$15 b
RedvaxJanuary 05, 2015
Baxter International - Marketed VaccinesJuly 30, 2014$635 m
InnoPharmaJuly 16, 2014$225 m
Show more

Pfizer Revenue Breakdown

Embed Graph

Pfizer revenue breakdown by business segment: 40.2% from Essential Health and 59.8% from Innovative Health

Pfizer revenue breakdown by geographic segment: 49.5% from United States, 16.2% from Developed Europe, 12.6% from Developed Rest of World and 21.7% from Emerging Markets

Pfizer Online and Social Media Presence

Embed Graph

Pfizer Company Culture

  • Overall Culture

    B

    69/100

  • CEO Rating

    C+

    68/100

  • Compensation

    B

    72/100

  • Diversity

    B-

    68/100

Learn more on Comparably

Pfizer News and Updates

Why Pfizer Looks Undervalued At $38

Pfizer’s stock has outperformed the broader markets as well as some of its peers over the last few weeks. While Pfizer stock grew 32.5% since the recent lows of March 23, the S&P 500 gained 28.0%. Looking at other pharmaceutical giants, Roche gained 29.3%, Novartis is up 18.8%, and Merck 20.2%..…

Pfizer Manages 35% Stock Growth Despite Revenue Decline

You don’t expect the stock of a large diversified company like Pfizer to return 30% in 3 years when the revenue is going down. However, that’s exactly what happened here! Large stock movements without any topline evidence are common in the pharmaceutical industry when promising drugs pass critical..

The Man Betting $1 Billion That Pfizer Can Deliver A Vaccine By This Fall

In the middle of March, Pfizer chief Albert Bourla beamed into a WebEx video call with the leaders of the American pharmaceutical giant’s vaccine research and manufacturing groups.

Pfizer says its coronavirus vaccine could be ready by this fall, and US testing could start as early as next week

US and German pharmaceutical companies Pfizer and BioNTech have partnered to develop a coronavirus vaccine that they hope could be available for emergency use by fall, The Wall Street Journal reported. BioNTech said the companies have already given the vaccine to 12 healthy people in Germany and a…

Stocks making the biggest moves after hours: United Airlines, Pfizer, KB Home & more

Check out the companies making headlines after the bell.

Pfizer discloses $185 million upfront payment to BioNTech for COVID-19 vaccine program

Shares of Pfizer Inc. were up 0.6% in premarket trading on Thursday after the drugmaker disclosed it is paying BioNTech $185 million for their COVID-19 vaccine development collaboration, with additional possible future milestone payments up to $563 million. BioNTech's stock gained 8.6% before the …
Show more

Pfizer Frequently Asked Questions

  • When was Pfizer founded?

    Pfizer was founded in 1849.

  • Who are Pfizer key executives?

    Pfizer's key executives are Frank D'Amelio, Mikael Dolsten and Angela Hwang.

  • How many employees does Pfizer have?

    Pfizer has 88,300 employees.

  • What is Pfizer revenue?

    Latest Pfizer annual revenue is $51.8 b.

  • What is Pfizer revenue per employee?

    Latest Pfizer revenue per employee is $586.1 k.

  • Who are Pfizer competitors?

    Competitors of Pfizer include Abbott, Bristol-Myers Squibb and Eli Lilly.

  • Where is Pfizer headquarters?

    Pfizer headquarters is located at 235 E 42nd St, New York.

  • Where are Pfizer offices?

    Pfizer has offices in New York, Melrose Park, Wien, Minsk and in 35 other locations.

  • How many offices does Pfizer have?

    Pfizer has 39 offices.